Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial.

Kendra KL, Bellasea SL, Eroglu Z, Hu-Lieskovan S, Campbell KM, Carson WE 3rd, Wada DA, Plaza JA, In GK, Ikeguchi A, Hyngstrom J, Brohl AS, Chmielowski B, Khushalani NI, Markowitz J, Monroe M, Contreras CM, Bowles T, Norman K, Medina E, Gonzalez CR, Baselga-Carretero I, Garcilazo IP, Vega-Crespo A, Chen JM, Deen NNA, Patel SP, Grossmann KF, Sondak VK, Sharon E, Moon J, Wu MC, Ribas A

Open source

DOI
10.1038/s43018-025-01113-y
Published
2026 Feb
Container
Nature cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s43018-025-01113-y,
  title = {Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial.},
  author = {Kendra KL and Bellasea SL and Eroglu Z and Hu-Lieskovan S and Campbell KM and Carson WE 3rd and Wada DA and Plaza JA and In GK and Ikeguchi A and Hyngstrom J and Brohl AS and Chmielowski B and Khushalani NI and Markowitz J and Monroe M and Contreras CM and Bowles T and Norman K and Medina E and Gonzalez CR and Baselga-Carretero I and Garcilazo IP and Vega-Crespo A and Chen JM and Deen NNA and Patel SP and Grossmann KF and Sondak VK and Sharon E and Moon J and Wu MC and Ribas A},
  year = {2026},
  journal = {Nature cancer},
  doi = {10.1038/s43018-025-01113-y},
  url = {https://doi.org/10.1038/s43018-025-01113-y}
}

RIS

TY  - JOUR
TI  - Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial.
AU  - Kendra KL
AU  - Bellasea SL
AU  - Eroglu Z
AU  - Hu-Lieskovan S
AU  - Campbell KM
AU  - Carson WE 3rd
AU  - Wada DA
AU  - Plaza JA
AU  - In GK
AU  - Ikeguchi A
AU  - Hyngstrom J
AU  - Brohl AS
AU  - Chmielowski B
AU  - Khushalani NI
AU  - Markowitz J
AU  - Monroe M
AU  - Contreras CM
AU  - Bowles T
AU  - Norman K
AU  - Medina E
AU  - Gonzalez CR
AU  - Baselga-Carretero I
AU  - Garcilazo IP
AU  - Vega-Crespo A
AU  - Chen JM
AU  - Deen NNA
AU  - Patel SP
AU  - Grossmann KF
AU  - Sondak VK
AU  - Sharon E
AU  - Moon J
AU  - Wu MC
AU  - Ribas A
PY  - 2026
JO  - Nature cancer
DO  - 10.1038/s43018-025-01113-y
UR  - https://doi.org/10.1038/s43018-025-01113-y
ER  - 

APA

KL, K., SL, B., Z, E., S, H., KM, C., 3rd, C. W., DA, W., JA, P., GK, I., A, I., J, H., AS, B., B, C., NI, K., J, M., M, M., CM, C., T, B., K, N., E, M., CR, G., I, B., IP, G., A, V., JM, C., NNA, D., SP, P., KF, G., VK, S., E, S., J, M., MC, W., & A, R. (2026). Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial.. Nature cancer. https://doi.org/10.1038/s43018-025-01113-y

Source records